Home » PRAECIS PHARMACEUTICALS INCORPORATED REPORTS FOURTH QUARTER AND YEAR END 2005 FINANCIAL RESULTS
PRAECIS PHARMACEUTICALS INCORPORATED REPORTS FOURTH QUARTER AND YEAR END 2005 FINANCIAL RESULTS
Praecis Pharmaceuticals Incorporated today announced consolidated financial
results for the three months and year ended December 31, 2005. The Company's
net loss for the three months ended December 31, 2005 was approximately $1,300,000,
or $0.12 per diluted share, compared to a net loss of approximately $13,422,000,
or $1.28 per diluted share, for the three months ended December 31, 2004.
Black
Enterprise
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May